http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007146171-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6abb831af25a744b4048ca0922e646e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a0165f2adfa713d103ae0c95e04f4496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df952ab42d0b251eb42c83150f64c628
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09fc02a407043ca0a10e2dbe5fcb6159
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-042
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-5759
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
filingDate 2007-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aca3fa2a963231b9c9e98b78ead3cf5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_816ad1492da39b4bc95ac2d351ed8137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c78d007a6e53831300c06a90c60de8f0
publicationDate 2008-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007146171-A3
titleOfInvention Purified high molecular weight adiponectin and uses thereof
abstract The present invention relates to high molecular weight (HMW) adiponectin, methods for its purification, and uses of the HMW adiponectin. Embodiments of the inventions includes an isolated and purified adiponectin complex composed of 18 adiponectin monomers substantially free of adiponectin trimers and hexamers; an article of manufacture comprising the HMW adiponectin complex and instructions for use of the complex in a mammalian patient; a method of preparing a purified HMW adiponectin; a method of predicting the risk of developing Type 2 diabetes by analyzing the HMW adiponectin content in a blood plasma; and a method of determining the effectiveness of a Type 2 diabetes treatment.
priorityDate 2006-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22957085
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128044035
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129095408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128912572
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128510671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446996
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127909126
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4362

Total number of triples: 30.